BROOKS

Brooks Laboratories Shareholding Pattern

₹58.90-1.27%
Market cap
₹174 crore
P/E
13.1
P/B
1.41
ROE
22.3%
Dividend yield
1.20%

As of 30-JUN-2026, promoters held 52.62% of Brooks Laboratories (0.00 pp from 31-MAR-2026), foreign institutional investors 0.00%, domestic institutions 10.38% and the public 37.00%.

Brooks Laboratories shareholding pattern

Percentage of shares held, by quarter, newest first.

Brooks Laboratories shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters52.62%52.62%52.62%52.62%52.62%n/a0.00 pp
Foreign institutions (FII/FPI)0.00%0.17%0.09%0.01%0.00%n/a-0.17 pp
Domestic institutions (DII)10.38%10.38%10.38%10.38%10.38%n/a0.00 pp
Government0.00%n/an/a0.00%0.00%n/a—
Public37.00%36.84%36.91%37.00%37.00%n/a+0.16 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Brooks Laboratories shareholding pattern — frequently asked questions

What is the promoter holding in Brooks Laboratories?

Promoters held 52.62% of Brooks Laboratories as of 30-JUN-2026, unchanged from 52.62% in 31-MAR-2026.

How much do FIIs hold in Brooks Laboratories?

Foreign institutional investors held 0.00% of Brooks Laboratories as of 30-JUN-2026, a change of -0.17 pp from the previous quarter.

How much do domestic institutions hold in Brooks Laboratories?

Domestic institutional investors, including mutual funds and insurers, held 10.38% of Brooks Laboratories as of 30-JUN-2026 (0.00 pp from the previous quarter).

Who owns Brooks Laboratories?

As of 30-JUN-2026, Brooks Laboratories' shareholders were promoters (52.62%), foreign institutional investors 0.00%, domestic institutions 10.38% and the public 37.00%, as filed with the stock exchanges.

Same Data For Peers

Trade Brooks Laboratories With ATS

Track BROOKS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.